Article Details

Bio-Thera Solutions Announces Commercialization and License Agreement for BAT1706, a ...

Retrieved on: 2021-09-08 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

Bio-Thera Solutions Announces Commercialization and License Agreement for BAT1706, a .... View article details on hiswai:

Excerpt

Bevacizumab is a humanized monoclonal antibody that targets VEGF. ... and innovative anti-OX40, anti-TIGIT, and anti-PD-L1/CD47 bispecific antibodies.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up